BridgeMD
New treatment option for Venous Catheterization
Official title GLUEPED2024: Study on the Use of Peripheral Venous Catheters in Pediatric Patients With Emergency Room Access.
ClinicalTrials.gov ID: NCT07450729
What this study is testing
- What it's testing
- A venous access device (VADs) is a biocompatible plastic catheter that establishes a connection between the skin surface and a venous system. They can be categorized using various classifications; notably, based on the position of the catheter tip, they are distinguished into central venous catheters (CVCs) and peripheral venous catheters (PVCs).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 0 to 18
You may be able to join if
- Age 0-18 years old
- Venous access device for at least 24 hours.
- Informed consent form signed
You likely can't join if
- Patients with language barriers
- patients with pre-existing central venous access
- patients requiring immediate surgery with venous access placed under sedation
- skin lesions in the affected area
- patients exhibiting psychomotor agitation
- patients assigned to the emergency code
See the full eligibility criteria
- Age 0-18 years old
- Venous access device for at least 24 hours.
- Informed consent form signed
- Patients with language barriers
- patients with pre-existing central venous access
- patients requiring immediate surgery with venous access placed under sedation
- skin lesions in the affected area
- patients exhibiting psychomotor agitation
- patients assigned to the emergency code
- unaccompanied minors
The study team makes the final eligibility decision.
Where it's taking place
- Florence, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 0 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Florence, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.